Clinical Trials

1,030 enrolled 24 charts

Phase 1 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT05479578 2025-01-08

Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer

7 enrolled

Castration-Resistant Prostate Carcinoma

NCT04907227 2024-07-12

KEYNOTE-921

Phase 3 Terminated

81 enrolled 19 charts

Phase 2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04147806 2024-06-11

PROSINT

30 enrolled

Prostatic Neoplasms

NCT03432949 2024-01-24

TRANCE

Phase 4 Unknown

24 enrolled

Prostatic Neoplasms

NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Classical hematologyGenitourinary

282 enrolled

Anemia, Fatigue, Prostatic Neoplasms

NCT00288080 2022-06-21

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

612 enrolled 11 charts

Prostatic Neoplasms

NCT01036594 2020-06-29

Keto/Dex

32 enrolled 10 charts

Prostatic Neoplasms

NCT01867710 2019-07-05

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

164 enrolled 22 charts

Hyperaldosteronism, Prostatic Neoplasms

NCT02047253 2018-12-19

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

28 enrolled 12 charts

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms

NCT02491411 2018-07-12

DEXTER

Phase NA Terminated

5 enrolled 5 charts

Prostatic Neoplasms

NCT00524589 2017-11-20

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Terminated

18 enrolled 7 charts

GenitourinaryGynecologicLymphoidPlasma cellThoracic

Prostatic Neoplasms

NCT00531284 2017-08-15

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Phase 1/2 Completed

184 enrolled 36 charts

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT01236586 2017-07-02

RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia

Phase 1 Withdrawn

CNSGenitourinaryLymphoidSarcoma

Brain Neoplasms, Lymphoma, Neoplasms, Wilms Tumor, Sarcoma, Osteosarcoma

NCT03193788 2017-06-21

PREMIER

Phase 3 Unknown

74 enrolled

BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms

NCT00248547 2017-05-09

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Phase NA Completed

40 enrolled 8 charts

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Nausea, Neoplasms, Neuroblastoma, Sezary Syndrome, Testicular Neoplasms, Vomiting, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT02441894 2017-01-24

PEGAZUS

Phase 4 Completed

21 enrolled

Prostatic Neoplasms

NCT01188187 2016-10-14

SYNERGY

1,022 enrolled

Prostatic Neoplasms

NCT01736917 2016-05-25

Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

65 enrolled 14 charts

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Vomiting

NCT00024167 2016-03-22

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Phase 3 Terminated

265 enrolled 9 charts

BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Prostatic Neoplasms

NCT00293384 2016-03-15

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Phase NA Completed

40 enrolled 9 charts

Testicular Germ Cell Tumor, Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Nausea, Neuroblastoma, Ovarian Neoplasms, Sezary Syndrome, Testicular Neoplasms, Vomiting, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00479089 2015-11-02

Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer

Phase 2 Terminated

50 enrolled 5 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00176293 2015-04-21

Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer

Phase 2 Terminated

2 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT00010231 2015-03-30

Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 1 Completed

22 enrolled

Prostatic Neoplasms

NCT01490437 2014-09-25

PECULIAR

42 enrolled

Carcinoma, Transitional Cell

NCT00473746 2014-04-29

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

Phase 1/2 Completed

66 enrolled 22 charts

Prostatic Neoplasms

NCT00473512 2014-03-27

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Phase 1/2 Completed

54 enrolled 20 charts

Prostatic Neoplasms

NCT01250717 2014-02-04

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

28 enrolled 5 charts

Prostatic Neoplasms

NCT00006002 2013-09-05

SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

36 enrolled

Prostatic Neoplasms

NCT00316927 2013-06-26

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

260 enrolled

Prostatic Neoplasms

NCT00559481 2013-02-01

Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

Phase NA Withdrawn

Prostatic Neoplasms

NCT00054522 2011-03-08

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy

15 enrolled